CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Celgene Corp  (CELG)
Other Ticker:  
 

Cumulative Celgene's Working Capital Ratio for Trailing Twelve Months Period

CELG's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CELG Working Capital Ratio for Trailing Twelve Months Period

 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Current Liabilities Growth 36 % -18.15 % 26.97 % 35.82 % -9.04 %
Y / Y Current Assets Growth 84.67 % 85.07 % 39.49 % -39.11 % -47.05 %
Working Capital Ratio for Trailing Twelve Months Period 2.82 2.64 2.14 2.06 2.62
Total Ranking # 1349 # 1486 # 1963 # 2068 # 1482
Seq. Current Liabilities Growth 35.93 % -6.83 % -2.51 % 10.15 % -18.19 %
Seq. Current Assets Growth 13.96 % 15.5 % 21.11 % 15.84 % 14.21 %

CELG Segments >> Back to CELG Financial Strength Comparisons >> Compare CELG Debt to Equity Ratio to its Competitors

Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2019
On the trailing twelve months basis Celgene Corp Current Assets average soared by 84.67% in III. Quarter year on year, faster than Current Liabilities, this led to increase in in Celgene's Working Capital Ratio for Trailing Twelve Months Period to 2.82, Working Capital Ratio for Trailing Twelve Months Period remained below Celgene Corp average.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 290 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Celgene. While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about CELG
Working Capital Ratio CELG in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 291
Sector # 504
S&P 500 # 1251


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.73 4.84 2.06
(March 31, 2007)   (Dec 31 2018)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2019, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Odonate Therapeutics Inc   7.74 
Eledon Pharmaceuticals Inc   7.69 
Beigene ltd   7.67 
Flexion Therapeutics Inc   7.57 
Spyre Therapeutics Inc   7.57 
Blueprint Medicines Corporation  7.50 
Procyon Corporation  7.44 
Corcept Therapeutics Inc  7.41 
Amicus Therapeutics inc   7.24 
Talphera Inc   7.22 
Enlivex Therapeutics Ltd   7.20 
Tonix Pharmaceuticals Holding Corp   7.19 
Y mabs Therapeutics inc   7.12 
Essa Pharma inc   7.11 
Benitec Biopharma Inc   7.10 
Caladrius Biosciences Inc   7.05 
Syros Pharmaceuticals Inc   7.02 
Arvinas Inc   7.02 
Rhythm Pharmaceuticals inc   6.90 
Evolus Inc   6.88 
Atossa Therapeutics Inc   6.72 
Karyopharm Therapeutics Inc   6.70 
Alnylam Pharmaceuticals Inc   6.67 
Zogenix Inc   6.66 
Marinus Pharmaceuticals Inc   6.66 
Vascular Biogenics Ltd   6.63 
Cellectar Biosciences inc   6.51 
Kyto Technology And Life Science Inc   6.50 
Aimmune Therapeutics Inc   6.50 
Optinose Inc   6.48 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com